Artivion Return on Tangible Equity 2010-2025 | AORT
Current and historical return on tangible equity values for Artivion (AORT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Artivion Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.02B | $-0.11B | 18.67% |
| 2024-12-31 | $-0.01B | $-0.12B | 10.41% |
| 2024-09-30 | $0.00B | $-0.11B | 0.00% |
| 2024-06-30 | $-0.01B | $-0.11B | 6.25% |
| 2024-03-31 | $-0.01B | $-0.12B | 6.68% |
| 2023-12-31 | $-0.03B | $-0.14B | 21.87% |
| 2023-09-30 | $-0.03B | $-0.14B | 17.51% |
| 2023-06-30 | $-0.03B | $-0.14B | 19.76% |
| 2023-03-31 | $-0.03B | $-0.15B | 20.20% |
| 2022-12-31 | $-0.02B | $-0.14B | 12.79% |
| 2022-09-30 | $-0.04B | $-0.16B | 27.20% |
| 2022-06-30 | $-0.02B | $-0.15B | 10.79% |
| 2022-03-31 | $-0.01B | $-0.15B | 9.11% |
| 2021-12-31 | $-0.01B | $-0.15B | 8.70% |
| 2021-09-30 | $0.00B | $-0.15B | -1.84% |
| 2021-06-30 | $-0.01B | $-0.17B | 6.71% |
| 2021-03-31 | $-0.01B | $-0.18B | 9.83% |
| 2020-12-31 | $-0.02B | $-0.16B | 16.43% |
| 2020-09-30 | $-0.02B | $-0.15B | 19.05% |
| 2020-06-30 | $-0.01B | $-0.04B | 21.72% |
| 2020-03-31 | $-0.01B | $-0.06B | 8.37% |
| 2019-12-31 | $0.00B | $-0.06B | -3.21% |
| 2019-09-30 | $0.00B | $-0.06B | -6.06% |
| 2019-06-30 | $0.00B | $-0.06B | -5.73% |
| 2019-03-31 | $0.00B | $-0.07B | -1.31% |
| 2018-12-31 | $0.00B | $-0.07B | 3.68% |
| 2018-09-30 | $-0.01B | $-0.08B | 8.16% |
| 2018-06-30 | $-0.01B | $-0.09B | 12.90% |
| 2018-03-31 | $0.00B | $-0.09B | 50.00% |
| 2017-12-31 | $0.00B | $-0.09B | 8.76% |
| 2017-09-30 | $0.01B | $0.08B | 12.33% |
| 2017-06-30 | $0.01B | $0.08B | 16.30% |
| 2017-03-31 | $0.01B | $0.07B | 16.26% |
| 2016-12-31 | $0.01B | $0.06B | 19.56% |
| 2016-09-30 | $0.01B | $0.06B | 15.44% |
| 2016-06-30 | $0.01B | $0.05B | 11.56% |
| 2016-03-31 | $0.01B | $0.05B | 6.80% |
| 2015-12-31 | $0.00B | $0.12B | 3.33% |
| 2015-09-30 | $0.00B | $0.12B | 2.54% |
| 2015-06-30 | $0.00B | $0.12B | 2.58% |
| 2015-03-31 | $0.01B | $0.12B | 5.22% |
| 2014-12-31 | $0.01B | $0.12B | 6.14% |
| 2014-09-30 | $0.01B | $0.11B | 12.42% |
| 2014-06-30 | $0.02B | $0.11B | 13.70% |
| 2014-03-31 | $0.02B | $0.11B | 14.25% |
| 2013-12-31 | $0.02B | $0.11B | 15.92% |
| 2013-09-30 | $0.01B | $0.10B | 9.38% |
| 2013-06-30 | $0.01B | $0.10B | 8.58% |
| 2013-03-31 | $0.01B | $0.09B | 9.89% |
| 2012-12-31 | $0.01B | $0.09B | 8.70% |
| 2012-09-30 | $0.01B | $0.09B | 8.60% |
| 2012-06-30 | $0.01B | $0.09B | 8.49% |
| 2012-03-31 | $0.01B | $0.10B | 7.31% |
| 2011-12-31 | $0.01B | $0.10B | 8.18% |
| 2011-09-30 | $0.01B | $0.10B | 8.02% |
| 2011-06-30 | $0.00B | $0.09B | 2.94% |
| 2011-03-31 | $0.00B | $0.11B | 3.76% |
| 2010-12-31 | $0.00B | $0.11B | 3.76% |
| 2010-09-30 | $0.00B | $0.10B | 3.77% |
| 2010-06-30 | $0.01B | $0.11B | 8.55% |
| 2010-03-31 | $0.01B | $0.11B | 8.78% |
| 2009-12-31 | $0.01B | $0.10B | 9.05% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.271B | $0.389B |
| Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants. Artivion Inc., formerly known as CryoLife Inc., is headquartered in suburban Atlanta, Georgia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.994B | 86.72 |
| Thermo Fisher Scientific (TMO) | United States | $151.802B | 18.36 |
| Edwards Lifesciences (EW) | United States | $44.969B | 29.49 |
| Alcon (ALC) | Switzerland | $42.113B | 28.46 |
| IDEXX Laboratories (IDXX) | United States | $41.363B | 47.53 |
| DexCom (DXCM) | United States | $34.106B | 52.72 |
| STERIS (STE) | Ireland | $24.071B | 26.54 |
| Mettler-Toledo (MTD) | United States | $24.056B | 28.61 |
| IQVIA Holdings (IQV) | United States | $24.009B | 13.45 |
| Waters (WAT) | United States | $21.101B | 29.77 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.538B | 0.00 |
| Hologic (HOLX) | United States | $14.197B | 15.43 |
| Sysmex ADR (SSMXY) | Japan | $10.588B | 30.04 |
| Penumbra (PEN) | United States | $10.235B | 80.33 |
| Masimo (MASI) | United States | $8.405B | 31.00 |
| Globus Medical (GMED) | United States | $8.016B | 19.10 |
| Glaukos (GKOS) | United States | $5.426B | 0.00 |
| Teleflex (TFX) | United States | $5.351B | 8.83 |
| TransMedics (TMDX) | United States | $4.350B | 94.57 |
| Integer Holdings (ITGR) | United States | $4.166B | 21.83 |
| PROCEPT BioRobotics (PRCT) | United States | $3.244B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.333B | 13.89 |
| Nihon Kohden (NHNKY) | Japan | $2.223B | 25.49 |
| Veracyte (VCYT) | United States | $2.093B | 29.36 |
| Elekta AB (EKTAY) | Sweden | $2.075B | 18.66 |
| Alphatec Holdings (ATEC) | United States | $1.818B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.409B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.206B | 0.00 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.987B | 5.25 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| IRadimed (IRMD) | United States | $0.657B | 33.33 |
| RxSight (RXST) | United States | $0.654B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.575B | 8.94 |
| Delcath Systems (DCTH) | United States | $0.564B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.560B | 13.18 |
| AxoGen (AXGN) | United States | $0.499B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.496B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.461B | 12.26 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.443B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.417B | 0.00 |
| NeuroPace (NPCE) | United States | $0.409B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.368B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.253B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.86 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.187B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.103B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 48.40 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.71 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.45 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |